Update on the National Vaccine Injury Compensation Program.
The National Childhood Vaccine Injury Act of 1986, as amended, established the Vaccine Injury Compensation Program (VICP). The VICP went into effect on October 1, 1988 and is a Federal "no-fault" system designed to compensate individuals, or families of individuals, who have been injured by covered vaccines. From 1988 until July 2006, a total of 2531 non-autism/thimerosal and 5030 autism/thimerosal claims were made to the VICP. The compensation paid for the non-autism/thimerosal claims from 1988 until 2006 was $902,519,103.37 for 2542 awards. There was no compensation for any of the autism/thimerosal claims. On the basis of the deaths and extensive suffering to patients and families from the adverse reactions to vaccines, all physicians must provide detailed information in the Vaccine Information Statement to the patient or the parent or legal guardian of the child about the potential dangers of vaccines as well as the VICP.
Edlich
Richard F
RF
Distinguished Professor of Plastic Surgery, Biomedical Engineering and Emergency Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.
Olson
Dana M
DM
Olson
Brianna M
BM
Greene
Jill Amanda
JA
Gubler
K Dean
KD
Winters
Kathryne L
KL
Kelley
Angela R
AR
Britt
L D
LD
Long
William B
WB
D000293:Adolescent; D001321:Autistic Disorder / Q000139:chemically induced / Q000191:economics; D002648:Child; D002675:Child, Preschool; D035881:Compensation and Redress / Q000331:legislation & jurisprudence*; D006801:Humans; D007223:Infant; D037141:Mandatory Programs / Q000331:legislation & jurisprudence; D032541:Mass Vaccination / Q000009:adverse effects / Q000331:legislation & jurisprudence; D010353:Patient Education as Topic / Q000331:legislation & jurisprudence; D028701:Patient Rights; D011310:Preservatives, Pharmaceutical / Q000009:adverse effects*; D013849:Thimerosal / Q000009:adverse effects* / Q000191:economics; D014342:Truth Disclosure; D014481:United States; D014612:Vaccines / Q000009:adverse effects* / Q000191:economics
D011310:Preservatives, Pharmaceutical; D014612:Vaccines; D013849:Thimerosal